Literature DB >> 11585983

The activity of collagen-degrading enzymes of Wharton's jelly in EPH gestosis (pre-eclampsia).

K Sobolewski1, Z Galewska, M Wolańska, S Jaworski.   

Abstract

Oedema/proteinuria/hypertension (EPH) gestosis is one of the more common complications observed during pregnancy. Our previous studies demonstrated some qualitative and quantitative changes in the extracellular matrix of Wharton's jelly in newborns delivered by mothers with EPH gestosis. For this reason it was decided to evaluate the effect of EPH gestosis on the activity of gelatinolytic and proteolytic enzymes which may be involved in collagen degradation in Wharton's jelly. Zymographic analysis of control and EPH gestosis samples of Wharton's jelly demonstrates different electrophoretic patterns of gelatinolytic enzymes. The control Wharton's jelly contains two latent forms of gelatinolytic enzymes: gelatinase A [metalloproteinase (MMP)-2, 72 kD] and gelatinase B (MMP-9, 92 kD). In contrast to control tissue, the main gelatinolytic enzyme of EPH gestosis Wharton's jelly is gelatinase A (MMP-2). It was found that the proteolytic activity in EPH gestosis Wharton's jelly differs from control. The decrease in gelatinase activity may be one of the factors which promote the accumulation of collagen in this tissue. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585983     DOI: 10.1159/000047143

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  3 in total

1.  Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells.

Authors:  Annamaria Mauro; Maria Buscemi; Aldo Gerbino
Journal:  J Mol Histol       Date:  2010-10-10       Impact factor: 2.611

Review 2.  Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension.

Authors:  Lech Romanowicz; Zofia Galewska
Journal:  J Pregnancy       Date:  2010-12-29

3.  Wharton's jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis.

Authors:  Olfat A Hammam; Nagwa Elkhafif; Yasmeen M Attia; Mohamed T Mansour; Mohamed M Elmazar; Rania M Abdelsalam; Sanaa A Kenawy; Aiman S El-Khatib
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.